ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 6,574,060 | $25,376,000 | 1.97% |
SENZAR ASSET MANAGEMENT, LLC | 1,040,681 | $4,017,000 | 0.98% |
Cormorant Asset Management, LP | 850,000 | $3,281,000 | 0.51% |
Palo Alto Investors LP | 2,135,739 | $8,244,000 | 0.41% |
Opus Point Partners Management, LLC | 99,959 | $386,000 | 0.32% |
Granahan Investment Management | 1,527,837 | $5,897,000 | 0.17% |
WALL STREET ASSOCIATES | 367,200 | $1,417,000 | 0.13% |
CAXTON CORP | 21,870 | $84,000 | 0.10% |
SHEPHERD KAPLAN KROCHUK, LLC | 107,392 | $415,000 | 0.07% |
Joel Isaacson & Co., LLC | 70,660 | $273,000 | 0.07% |